inobrodib
cellcentric
['pioneer', 'inobrodib']
great to be in chicago, #asco23. continuing to progress inobrodib, our pioneering oral p300/cbp inhibitor drug. making a difference to people with cancer. 
Inobrodib (CCS1477): first-in-class p300/CBP small molecule inhibitor drug, to treat specific cancers.